Study of Paclitaxel in Combination With BOS172722 in Patients With Advanced Nonhaematologic Malignancies

NCT03328494 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Nonhaematologic Malignancies

Interventions

DRUG: BOS172722
DRUG: Paclitaxel

Sponsor

Boston Pharmaceuticals